COLL Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 104669 min ago

@ $32.43

Wydano: 14 vas. 2024 @ 16:32

Zwrot: 12.30%

Poprzedni sygnał: vas. 13 - 16:30

Poprzedni sygnał: Kupno

Zwrot: -1.90 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	121 316
Średni wolumen	410 536
Kapitalizacja rynkowa	1.16B
EPS	$0 ( 2024-02-22 )
Następna data zysków	( $1.500 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	28.23
ATR14	$0.0310 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-29	Smith Thomas B	Sell	995	Common Stock
2024-02-26	Dreyer Scott	Sell	9 336	Common Stock
2024-02-26	Dreyer Scott	Sell	664	Common Stock
2024-02-12	Tupper Colleen	Buy	30 856	Common Stock
2024-02-12	Tupper Colleen	Sell	16 868	Common Stock

INSIDER POWER
14.83
Last 100 transactions
Buy: 1 331 449 \| Sell: 1 023 987

Wolumen Korelacja

Długi: 0.07 (neutral)

Krótki: -0.21 (neutral)

Signal:(47.312) Neutral

Collegium Pharmaceutical Korelacja

10 Najbardziej pozytywne korelacje
BNIXU	0.971
AHCO	0.934
MDRX	0.929
CARA	0.928
RKDA	0.927
ATRA	0.925
CSSE	0.925
DISH	0.924
ETSY	0.923
UPLD	0.922

10 Najbardziej negatywne korelacje
MSDA	-0.922
MTEK	-0.914
BRIVU	-0.911
VLAT	-0.91
TIOAU	-0.909
ADAL	-0.908
PPYAU	-0.906
NVCN	-0.902
BNIX	-0.902
BRIV	-0.899

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Collegium Pharmaceutical Korelacja - Waluta/Towar

0.59
( weak )

0.60
( weak )

0.00
( neutral )

0.62
( weak )

-0.16
( neutral )

-0.56
( weak negative )

Collegium Pharmaceutical Finanse

Annual	2023
Przychody:	$566.77M
Zysk brutto:	$326.17M (57.55 %)
EPS:	$1.430

FY	2023
Przychody:	$566.77M
Zysk brutto:	$326.17M (57.55 %)
EPS:	$1.430

FY	2022
Przychody:	$463.93M
Zysk brutto:	$209.49M (45.15 %)
EPS:	$-0.740

FY	2021
Przychody:	$276.87M
Zysk brutto:	$150.62M (54.40 %)
EPS:	$2.05

Financial Reports:

No articles found.

Collegium Pharmaceutical

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Aktualne aktualizacje dla Collegium Pharmaceutical [COLL]

Upcoming Earnings Alert